Plexiform Bioscience Inc. — Form D/A

Plexiform Bioscience Inc. of DOVER, DE, a company, filed a Form D amendment with the SEC on 2025-07-18. The offering totals $2.2M, of which $1.3M was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2025-07-18
• Form: D/A
• Accession: 0002048968-25-000001
• Industry: Pharmaceuticals
• Exemptions: 06b
• Total offering: $2.2M
• Amount sold: $1.3M
• Remaining: $860K
• Minimum investment: $50K
• Investors: 14
• Date of first sale: 2024-12-03
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-532304

Issuer

• Name: Plexiform Bioscience Inc.
• CIK: 0002048968
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2024
• Address: 8 THE GREEN NO 19634, DOVER, DE, 19901
• Phone: 7085137860

Officers, directors & promoters (1)

Other filings by this issuer (1)

More

• CIK 2048968 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search